| Gastric Cancer Management and Outcomes | Lifetime | 21 | ES 1 | 99.89 |
| Gastrointestinal disorders and treatments | Lifetime | 9 | ES 1 | 99.92 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 14 | ES 1 | 99.89 |
| Gastroesophageal reflux and treatments | Lifetime | 10 | ES 1 | 99.87 |
| Eosinophilic Esophagitis | Lifetime | 17 | ES 1 | 99.80 |
| Inflammatory Bowel Disease | Lifetime | 19 | ES 2 | 99.86 |
| Microscopic Colitis | Lifetime | 18 | ES 1 | 99.82 |
| Veterinary medicine and infectious diseases | Lifetime | 6 | ES 1 | 99.87 |
| Pregnancy and Medication Impact | Lifetime | 14 | ES 1 | 99.60 |
| Gastrointestinal Bleeding Diagnosis and Treatment | Lifetime | 16 | ES 1 | 99.54 |
| Autoimmune and Inflammatory Disorders | Lifetime | 40 | ES 2 | 99.16 |
| Galectins and Cancer Biology | Lifetime | 112 | ES 1 | 98.40 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 254 | ES 4 | 98.74 |
| Biosimilars and Bioanalytical Methods | Lifetime | 71 | ES 2 | 98.25 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 141 | ES 3 | 98.65 |
| Acute Lymphoblastic Leukemia research | Lifetime | 255 | ES 4 | 98.99 |
| Liver Diseases and Immunity | Lifetime | 121 | ES 4 | 98.75 |
| Intestinal and Peritoneal Adhesions | Lifetime | 87 | ES 1 | 97.94 |
| Diagnosis and treatment of tuberculosis | Lifetime | 158 | ES 5 | 97.87 |
| Reproductive System and Pregnancy | Lifetime | 637 | ES 12 | 97.03 |
| Gastrointestinal motility and disorders | Lifetime | 414 | ES 6 | 97.12 |
| Health and Medical Research Impacts | Lifetime | 205 | ES 4 | 95.20 |
| Iron Metabolism and Disorders | Lifetime | 590 | ES 8 | 96.70 |
| Diverticular Disease and Complications | Lifetime | 550 | ES 14 | 95.76 |
| Celiac Disease Research and Management | Lifetime | 463 | ES 16 | 94.52 |
| Erythropoietin and Anemia Treatment | Lifetime | 701 | ES 25 | 91.11 |
| Potassium and Related Disorders | Lifetime | 883 | ES 19 | 85.95 |
| Psychology Research and Bibliometrics | Lifetime | 492 | ES 273 | 84.73 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 557 | ES 31 | 76.92 |
| Whipple's Disease and Interleukins | Lifetime | 358 | ES 2 | 74.01 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 3 | ES 1 | 99.63 |
| Gastroesophageal reflux and treatments | 2021-2025 | 10 | ES 1 | 99.15 |
| Inflammatory Bowel Disease | 2021-2025 | 25 | ES 2 | 99.67 |
| Pregnancy and Medication Impact | 2021-2025 | 8 | ES 2 | 98.75 |
| Microscopic Colitis | 2021-2025 | 24 | ES 2 | 99.56 |
| Veterinary medicine and infectious diseases | 2021-2025 | 4 | ES 1 | 97.75 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 19 | ES 1 | 98.47 |
| Diagnosis and treatment of tuberculosis | 2021-2025 | 16 | ES 2 | 96.80 |
| Eosinophilic Esophagitis | 2021-2025 | 49 | ES 2 | 98.68 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 174 | ES 1 | 98.25 |
| Health and Medical Research Impacts | 2021-2025 | 62 | ES 1 | 90.92 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 245 | ES 8 | 94.04 |
| Clostridium difficile and Clostridium perfringens research | 2021-2025 | 230 | ES 5 | 91.52 |
| Gastrointestinal disorders and treatments | 2021-2025 | 527 | ES 6 | 87.00 |
| Pharmaceutical studies and practices | 2021-2025 | 370 | ES 9 | 85.23 |
| Celiac Disease Research and Management | 2021-2025 | 247 | ES 19 | 85.15 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 286 | ES 11 | 80.74 |
| Liver Diseases and Immunity | 2021-2025 | 674 | ES 29 | 81.31 |
